Multidrug-Resistant Gram-Negative Bacilli: A Retrospective Study of Trends in a Tertiary Healthcare Unit

被引:24
|
作者
Muntean, Delia [1 ,2 ]
Horhat, Florin-George [1 ,3 ]
Baditoiu, Luminita [1 ]
Dumitrascu, Victor [1 ]
Bagiu, Iulia-Cristina [1 ]
Horhat, Delia-Ioana [1 ]
Cosnita, Dan A. [1 ]
Krasta, Anca [2 ]
Dugaesescu, Dorina [1 ]
Licker, Monica [1 ,2 ]
机构
[1] Victor Babes Univ Med & Pharm, Eftimie Murgu St 2, Timisoara 300041, Romania
[2] Pius Brinzeu Emergency Clin Cty Hosp, Liviu Rebreanu St 156, Timisoara 300723, Romania
[3] Children Emergency Louis Turcanu Timisoara, Iosif Nemoianu St 2, Timisoara 300011, Romania
来源
MEDICINA-LITHUANIA | 2018年 / 54卷 / 06期
关键词
multidrug-resistant; Gram-negative bacilli; tertiary hospital; ANTIMICROBIAL RESISTANCE; ACINETOBACTER-BAUMANNII; NOSOCOMIAL INFECTIONS; RISK-FACTORS; ANTIBIOTIC-THERAPY; BACTEREMIA; SUSCEPTIBILITY; PATHOGENS; ENTEROBACTERIACEAE; RECOMMENDATIONS;
D O I
10.3390/medicina54060092
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objective: Bacterial multidrug resistance is particularly common in Gram-negative bacilli (GNB), with important clinical consequences regarding their spread and treatment options. The aim of this study was to investigate the trend of multidrug-resistant GNB (MDR-GNB) in high-risk hospital departments, between 2000-2015, in intervals of five years, with the intention of improving antibiotic therapy policies and optimising preventive and control practices. Materials and methods: This is an observational, retrospective study performed in three departments of the most important tertiary healthcare unit in the southwestern part of Romania: the Intensive Care Unit (ICU), the General Surgery Department (GSD), and the Nutrition and Metabolic Diseases Department (NMDD). MDR was defined as acquired resistance to at least one agent in three or more antimicrobial categories. Trends over time were determined by the Cochran-Armitage trend test and linear regression. Results: During the study period, a total of 2531 strains of MDR-GNB were isolated in 1999 patients: 9.20% in 2000, 18.61% in 2005, 37.02% in 2010, and 35.17% in 2015. The most significant increasing trend was recorded in the ICU (gradient = 7.63, R-2 = 0.842, p < 0.001). The most common MDR-GNB in the ICU was isolated from bronchoalveolar aspiration samples. Concerning the proportion of different species, most of the changes were recorded in the ICU, where a statistically significant increasing trend was observed for Proteus mirabilis (gradient = 2.62, R-2 = 0.558, p < 0.001) and Acinetobacter baumannii (gradient = 2.25, R-2 = 0.491, p < 0.001). Analysis of the incidence of the main resistance phenotypes proportion identified a statistically significant increase in carbapenem resistance in the ICU (Gradient = 8.27, R-2 = 0.866, p < 0.001), and an increased proportion of aminoglycoside-resistant strains in all three departments, but more importantly in the ICU and GSD. Conclusion: A statistically significant increasing trend was observed in all three departments; the most significant one was recorded in the ICU, where after 2010, carbapenem-resistant strains were isolated.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] The rising influx of multidrug-resistant gram-negative bacilli into a tertiary care hospital
    Pop-Vicas, AE
    D'Agata, EMC
    CLINICAL INFECTIOUS DISEASES, 2005, 40 (12) : 1792 - 1798
  • [2] Epidemiology and clinical characteristics of patients with healthcare-acquired multidrug-resistant Gram-negative bacilli: a retrospective study from a tertiary care hospital
    Aiesh, Banan M.
    Natsheh, Mustafa
    Amar, Mohammad
    Abutaha, Shatha
    Qadi, Mohammad
    Abutaha, Adham
    Sabateen, Ali
    Zyoud, Sa'ed H.
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [3] Multidrug-Resistant Gram-Negative Bacilli: Infection Control Implications
    Adler, Amos
    Friedman, N. Deborah
    Marchaim, Dror
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2016, 30 (04) : 967 - +
  • [4] Facing the challenge of multidrug-resistant gram-negative bacilli in Australia
    Harris, Patrick
    Paterson, David
    Rogers, Benjamin
    MEDICAL JOURNAL OF AUSTRALIA, 2015, 202 (05) : 243 - +
  • [5] Trends in Multidrug-Resistant Gram-Negative Bacilli and the Role of Prolonged beta-Lactam Infusion in the Intensive Care Unit
    Guervil, David J.
    Chau, Terence
    CRITICAL CARE NURSING QUARTERLY, 2013, 36 (04) : 345 - 355
  • [6] Treatment of Carbapenem-Resistant Multidrug-Resistant Gram-Negative Bacilli with Intracerebroventricular Injection of Polymyxin B A Retrospective study
    Liu, Dongsheng
    Niu, Jianxing
    Chen, Guoqiang
    Xu, Long
    INFECTION AND DRUG RESISTANCE, 2022, 15 : 7653 - 7666
  • [7] Carriage of multidrug-resistant Gram-negative bacilli: duration and risk factors
    Herrera, S.
    Torralbo, B.
    Herranz, S.
    Bernal-Maurandi, J.
    Rubio, E.
    Pitart, C.
    Fortes, I.
    Valls, S.
    Rodriguez, L.
    Santana, G.
    Bodro, M.
    Garcia-Vidal, C.
    Hernandez-Meneses, M.
    Puerta, P.
    Morata, L.
    Villella, A.
    Bertran, M. J.
    Brey, M.
    Soriano, A.
    Del Rio, A.
    Martinez, J. A.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2023, 42 (05) : 631 - 638
  • [8] Risk factors and outcomes for multidrug-resistant Gram-negative bacilli bacteremia
    Patolia, Swati
    Abate, Getahun
    Patel, Nirav
    Patolia, Setu
    Frey, Sharon
    THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2018, 5 (01) : 11 - 18
  • [9] New treatments for multidrug-resistant nonfermenting Gram-negative bacilli Infections
    Chumbita, Mariana
    Monzo-Gallo, Patricia
    Lopera-Marmol, Carlos
    Francesco Aiello, Tommaso
    Puerta-Alcalde, Pedro
    Garcia-Vidal, Carolina
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2022, 35 : 51 - 53
  • [10] Carriage of multidrug-resistant Gram-negative bacilli: duration and risk factors
    S. Herrera
    B. Torralbo
    S. Herranz
    J. Bernal-Maurandi
    E. Rubio
    C. Pitart
    I. Fortes
    S. Valls
    L. Rodríguez
    G. Santana
    M. Bodro
    C. Garcia-Vidal
    M. Hernández-Meneses
    P. Puerta
    L. Morata
    A. Villella
    M. J. Bertran
    M. Brey
    A. Soriano
    A. Del Río
    J. A. Martinez
    European Journal of Clinical Microbiology & Infectious Diseases, 2023, 42 : 631 - 638